TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $42,816,000 | -33.8% | 1,600,000 | -51.8% | 3.85% | -25.5% |
| Q2 2020 | $64,689,000 | +84.9% | 3,320,808 | -6.6% | 5.17% | +41.4% |
| Q1 2020 | $34,994,000 | -42.0% | 3,556,324 | -34.6% | 3.66% | -30.4% |
| Q4 2019 | $60,326,000 | +390.5% | 5,434,783 | +81.2% | 5.25% | +237.8% |
| Q4 2018 | $12,300,000 | +12.6% | 3,000,000 | +53.8% | 1.56% | -8.6% |
| Q3 2018 | $10,920,000 | – | 1,950,000 | – | 1.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |